These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5515631)

  • 1. Geographic and secular variation in mortality from malignant disease in Oklahoma, 1956-1965.
    Assal NR; Lindeman RD
    J Okla State Med Assoc; 1970 Oct; 63(10):469-80. PubMed ID: 5515631
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality trend of hematologic and lymphatic malignancy (lymphoma, multiple myeloma and leukemia) in Japan: 1960-2000.
    Yoshimi I; Kaneko S
    Jpn J Clin Oncol; 2004 Apr; 34(4):218-25. PubMed ID: 15190904
    [No Abstract]   [Full Text] [Related]  

  • 3. Geographic and secular variation in mortality from malignant disease in Oklahoma 1956-1965. 3. Cancer of the gastrointestinal tract.
    Assal NR; Lindeman RD
    J Okla State Med Assoc; 1970 Jan; 63(1):17-28. PubMed ID: 5511574
    [No Abstract]   [Full Text] [Related]  

  • 4. Mortality trends of hematologic neoplasms (lymphoma, myeloma, and leukemia) in Japan (1960-2000): with special reference to birth cohort.
    Yoshimi I; Mizuno S
    Jpn J Clin Oncol; 2004 Oct; 34(10):634-7. PubMed ID: 15591464
    [No Abstract]   [Full Text] [Related]  

  • 5. A descriptive epidemiological study of hematopoietic neoplasms in Japan.
    Kato I; Tajima K; Hirose K; Nakagawa N; Kuroishi T; Tominaga S
    Jpn J Clin Oncol; 1985 Jun; 15(2):347-64. PubMed ID: 4021118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia, lymphomas, and myeloma mortality in the vicinity of nuclear power plants and nuclear fuel facilities in Spain.
    López-Abente G; Aragonés N; Pollán M; Ruiz M; Gandarillas A
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):925-34. PubMed ID: 10548323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Causes of death in hematopoietic malignancies--increasing incidences of gastrointestinal bleeding].
    Sawada H; Nishikori M; Mochizuki T; Ishikura H; Izumi Y; Usui T; Konishi H; Uchino H
    Rinsho Ketsueki; 1983 Feb; 24(2):119-25. PubMed ID: 6606717
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in survival in haematological malignancies.
    Holmes FF
    East Afr Med J; 1972 Feb; 49(2):67-74. PubMed ID: 4505629
    [No Abstract]   [Full Text] [Related]  

  • 9. Geoaphic and secular variation n mortality from malignant disease in Oklahoma 1956-1965.
    Assal NR; Lindeman RD
    J Okla State Med Assoc; 1969 Sep; 62(9):424-33. PubMed ID: 5823699
    [No Abstract]   [Full Text] [Related]  

  • 10. Geographic and secular variations in malignant disease in Oklahoma, 1956-65.
    Assal NR; Lindeman RD
    J Okla State Med Assoc; 1969 Oct; 62(10):473-82. PubMed ID: 5406879
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial factors relating to prognosis of leukemia and lymphoma.
    Rosenlof RC; Lemon HM; Rigby PG
    Natl Cancer Inst Monogr; 1971 Dec; 34():283-9. PubMed ID: 4946580
    [No Abstract]   [Full Text] [Related]  

  • 12. High cancer mortality rates from childhood leukemia and young adult Hodgkin's disease and lymphoma in the New Jersey-New York-Philadelphia Metropolitan Corridor, 1950 to 1969.
    Greenberg MR; Caruana J; Holcomb B; Greenberg G; Parker R; Louis J; White P
    Cancer Res; 1980 Feb; 40(2):439-43. PubMed ID: 7356527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia and lymphoma mortality and farm residence.
    Fasal E; Jackson EW; Klauber MR
    Am J Epidemiol; 1968 Mar; 87(2):267-74. PubMed ID: 4869663
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemia in close relatives--accident or predisposition?
    Gunz FW; Veale AM
    J Natl Cancer Inst; 1969 Mar; 42(3):517-24. PubMed ID: 4180615
    [No Abstract]   [Full Text] [Related]  

  • 15. Racial differences in the incidence and outcomes for patients with hematological malignancies.
    Flowers CR; Glover R; Lonial S; Brawley OW
    Curr Probl Cancer; 2007; 31(3):182-201. PubMed ID: 17543947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognosis of hematological patients with relapse following high-dose chemotherapy and autologous stem cell transplantation].
    Baggers J; Johnsen HE
    Ugeskr Laeger; 1998 Sep; 160(38):5505-8. PubMed ID: 9763925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Causes of death in leukemia and malignant lymphoma: important role of mycoses and gramnegative infections].
    Sawada H; Nakamura T; Sato M; Kojima H; Wakizaka G
    Saishin Igaku; 1970 Feb; 5(2):414-22. PubMed ID: 4191347
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma in Oklahoma: racial, age, sex, geographic and time variations.
    Stober J; Asal NR
    South Med J; 1976 Mar; 69(3):298-302. PubMed ID: 1257825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing trends of multiple myeloma mortality in England and Wales; 1950-79: are the changes real?
    Velez R; Beral V; Cuzick J
    J Natl Cancer Inst; 1982 Aug; 69(2):387-92. PubMed ID: 6955544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant lymphoma in Papua New Guinea: epidemiologic aspects.
    Wilkey IS
    J Natl Cancer Inst; 1973 Jun; 50(6):1703-11. PubMed ID: 4717572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.